IRIS Accounts Production v24.3.0.553 04266747 director 1.8.23 31.7.24 31.7.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042667472023-07-31042667472024-07-31042667472023-08-012024-07-31042667472022-07-31042667472022-08-012023-07-31042667472023-07-3104266747ns15:EnglandWales2023-08-012024-07-3104266747ns14:PoundSterling2023-08-012024-07-3104266747ns10:Director12023-08-012024-07-3104266747ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3104266747ns10:SmallEntities2023-08-012024-07-3104266747ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3104266747ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3104266747ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3104266747ns10:FullAccounts2023-08-012024-07-310426674712023-08-012024-07-3104266747ns10:RegisteredOffice2023-08-012024-07-3104266747ns5:CurrentFinancialInstruments2024-07-3104266747ns5:CurrentFinancialInstruments2023-07-3104266747ns5:Non-currentFinancialInstruments2024-07-3104266747ns5:Non-currentFinancialInstruments2023-07-3104266747ns5:ShareCapital2024-07-3104266747ns5:ShareCapital2023-07-3104266747ns5:RetainedEarningsAccumulatedLosses2024-07-3104266747ns5:RetainedEarningsAccumulatedLosses2023-07-3104266747ns5:NetGoodwill2023-08-012024-07-3104266747ns5:LandBuildings2023-08-012024-07-3104266747ns5:PlantMachinery2023-08-012024-07-3104266747ns5:NetGoodwill2024-07-3104266747ns5:LandBuildings2023-07-3104266747ns5:PlantMachinery2023-07-3104266747ns5:LandBuildings2024-07-3104266747ns5:PlantMachinery2024-07-3104266747ns5:LandBuildings2023-07-3104266747ns5:PlantMachinery2023-07-3104266747ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3104266747ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-31
REGISTERED NUMBER: 04266747 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 July 2024

for

Tanday Pharmacy Limited

Tanday Pharmacy Limited (Registered number: 04266747)

Contents of the Financial Statements
for the Year Ended 31 July 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Tanday Pharmacy Limited

Company Information
for the Year Ended 31 July 2024







DIRECTOR: Mr Harmail Singh Sohal





REGISTERED OFFICE: Office 1,
Hatherton Court
Hatherton Street
Walsall
WS4 2LA





REGISTERED NUMBER: 04266747 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

Tanday Pharmacy Limited (Registered number: 04266747)

Balance Sheet
31 July 2024

31.7.24 31.7.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 128,047 -
Tangible assets 5 214,747 203,986
342,794 203,986

CURRENT ASSETS
Stocks 85,000 80,000
Debtors 6 999,130 663,847
Cash at bank and in hand 147,656 112,744
1,231,786 856,591
CREDITORS
Amounts falling due within one year 7 (1,047,614 ) (582,790 )
NET CURRENT ASSETS 184,172 273,801
TOTAL ASSETS LESS CURRENT
LIABILITIES

526,966

477,787

CREDITORS
Amounts falling due after more than
one year

8

(82,522

)

-

PROVISIONS FOR LIABILITIES (19,327 ) (10,811 )
NET ASSETS 425,117 466,976

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 425,107 466,966
SHAREHOLDERS' FUNDS 425,117 466,976

Tanday Pharmacy Limited (Registered number: 04266747)

Balance Sheet - continued
31 July 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 April 2025 and were signed by:





Mr Harmail Singh Sohal - Director


Tanday Pharmacy Limited (Registered number: 04266747)

Notes to the Financial Statements
for the Year Ended 31 July 2024


1. STATUTORY INFORMATION

Tanday Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2023, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - Straight line over 25 years
Plant and machinery etc - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Tanday Pharmacy Limited (Registered number: 04266747)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2023 - 9 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
Additions 137,193
At 31 July 2024 137,193
AMORTISATION
Charge for year 9,146
At 31 July 2024 9,146
NET BOOK VALUE
At 31 July 2024 128,047

Tanday Pharmacy Limited (Registered number: 04266747)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 August 2023 241,123 278,904 520,027
Additions - 30,657 30,657
At 31 July 2024 241,123 309,561 550,684
DEPRECIATION
At 1 August 2023 94,038 222,003 316,041
Charge for year 9,645 10,251 19,896
At 31 July 2024 103,683 232,254 335,937
NET BOOK VALUE
At 31 July 2024 137,440 77,307 214,747
At 31 July 2023 147,085 56,901 203,986

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors 266,704 156,127
Amounts owed by group undertakings 414,192 172,199
Other debtors 318,234 335,521
999,130 663,847

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Bank loans and overdrafts 25,849 -
Trade creditors 366,180 265,890
Taxation and social security 139,782 71,742
Other creditors 515,803 245,158
1,047,614 582,790

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.7.24 31.7.23
£    £   
Bank loans 82,522 -

Tanday Pharmacy Limited (Registered number: 04266747)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


9. RELATED PARTY DISCLOSURES

Included in other debtors is the balance due from the company mentioned below as at 31 July 2024:

Tamworth Pharma Limited - £135,000 (2023 - NIL)


Included in other creditors are the balances due to the companies mentioned below as at 31 July 2024:

LP SD Thirty Seven Limited £81,385 (2023 - NIL)
Seva Health Limited £10,500 (2023 - NIL)

The all above loans are interest free and repayable on demand.

Mr Harmail Singh Sohal is the director of above mentioned companies as at 31 July 2024.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Harmail Healthcare Limited.